January 28, 2015 7:39 AM ET

Pharmaceuticals

Company Overview of Nerveda, Inc.

Company Overview

Nerveda, Inc. operates as a pharmaceutical and diagnostic company. It focuses on neurodegenerative diseases. The company also engages in the clinical development of neuroprotective compounds and stem cell therapeutics for treating auto-immune disorders. Nerveda, Inc. is based in San Diego, California.

3888 Quarter Mile Drive

San Diego, CA 92130-1291

United States

Founded in 2007

Phone:

858-705-2365

Key Executives for Nerveda, Inc.

Chief Executive Officer and President
Age: 44
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Novartis Vaccines and Diagnostics, Inc. United States
Karo Bio USA, Inc. United States
Spear Pharmaceuticals, Inc. United States
Unidose Systems, Inc. United States
Outlook Pharmaceuticals Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 12, 2015
DioGenix, Inc.
Private Placement
June 29, 2014
RetroSense Therapeutics, LLC
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nerveda, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.